Anzatax

Anzatax Indications/Uses

paclitaxel

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma

Marketer:

DKSH
Full Prescribing Info
Indications/Uses
Anzatax Injection Concentrate is indicated for the primary treatment of ovarian cancer in combination with a platinum agent.
Anzatax Injection Concentrate is indicated for the treatment of metastatic ovarian cancer and metastatic breast cancer, after failure of standard therapy.
Anzatax Injection Concentrate is indicated for the treatment of non-small cell lung cancer (NSCLC).
Anzatax Injection Concentrate is indicated for the treatment of metastatic cancer of the breast, in combination with trastuzumab (Herceptin), in patients who have tumours that over-express HER-2 at 3+ level as determined by immunohistochemistry and who have not received previous chemotherapy for their metastatic disease.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in